Get startedLog in
    Picture of Universe Pharmaceuticals logo

    UPC — Universe Pharmaceuticals Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Universe Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

    2021
    September 30th
    C2022
    September 30th
    C2023
    September 30th
    2024
    September 30th
    2025
    September 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:20-F20-F20-F20-F20-F
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line11.3-7.91-6.58-8.73-3.67
    Depreciation
    Deferred Taxes
    Non-Cash Items-0.2290.017-0.0490.1860.371
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-12.96.66.62-2.06-2.27
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-2.06-1.31.12-9.51-5.05
    Capital Expenditures-0.445-0.094-0.044-0.326-0.347
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-26.6-3.810-0.0360.005
    Sale of Fixed Assets
    Other Investing Cash Flow
    Cash from Investing Activities-27.1-3.91-0.044-0.361-0.342
    Financing Cash Flow Items-2.79————
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities26.63.32-1.39349.73
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-1.98-2.37-0.42624.24.09